AngioDynamics to Present at 19th Annual Piper Jaffray Health Care Conference AngioDynamics to Present at 19th Annual Piper Jaffray Health Care Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 19, 2007--AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices used by

AngioDynamics to Present at the Canaccord Adams Cardiovascular Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 9, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer

Largest and Longest Study on Radiofrequency Ablation Study Published in the October Issue of Annals of Surgery

AngioDynamics Granted Summary Judgment Motion On Willfulness in VNUS Litigation AngioDynamics Granted Summary Judgment Motion On Willfulness in VNUS Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 29, 2007--AngioDynamics (NASDAQ:ANGO) today announced that its motion for summary judgment of no

Trial Date Postponed Due to Busy Court Calendar

Seasoned Executive Brings 18 Years of Global Financial Management and Accounting Expertise to Company

AngioDynamics Granted Patent for Laser Treatment Innovation AngioDynamics Granted Patent for Laser Treatment Innovation QUEENSBURY, N.Y., Oct 04, 2007 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons

AngioDynamics Announces Ruling in VNUS Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 3, 2007--AngioDynamics, Inc. (NASDAQ:ANGO) today announced the denial of cross-motions for summary judgment issued in the U.S. District Court in the Northern District of California in the patent litigation

-- Company Generates 85% Sales Growth<br>
<br>
-- Operating Income Increases 93%<br>
<br>
-- Net Income Grows 25% to $2.4 Million or $0.10 Per Share<br>
<br>
-- Adjusted (Non GAAP) Income Increases 158% to $6.1 Million or
$0.25 Per Share<br>
<br>

-- Fiscal 2008 Guidance Reaffirmed

AngioDynamics Announces Conference Call for First Quarter FY08 Financial Results AngioDynamics Announces Conference Call for First Quarter FY08 Financial Results QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 17, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by

AngioDynamics Elects Vincent Bucci as Chairman of the Board of Directors AngioDynamics Elects Vincent Bucci as Chairman of the Board of Directors QUEENSBURY, N.Y., Aug 28, 2007 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional

AngioDynamics Launches a Single Needle Radio Frequency Electrode for Multiple Small Lesion Ablations QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 20, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally

AngioDynamics to Present at the Canaccord Adams Global Growth Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 31, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer

AngioDynamics Promotes William Appling to Senior Vice President of Research and Development QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 30, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive

Hobbs: &#8216;Regulating Compounding Pharmacies Should Be
Key Patient Safety Plank in FDA Bill'

<li>Fourth Quarter Net Sales Up 73% to $40.9 Million</li>

<li>Fourth Quarter GAAP Net Income Grows 43.5% to $2.9 Million</li>

<li>Fourth Quarter Adjusted (Non-GAAP) Income Increases 225% to
$6.9 Million or $0.29 Per Share</li>

<li>Fourth Quarter Cash Flow from Operations of $5.3 Million</li>

<li>On Plan to Achieve Projected FY08 RITA Medical Cost Savings of
$9 Million</li>

<li>Additional Fiscal 2008 Guidance Provided</li>

AngioDynamics to Hold Fiscal 2007 Fourth Quarter and Full-Year Financial Results Conference Call on Tuesday, July 24, 2007 QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 12, 2007--AngioDynamics (NASDAQ:ANGO) today announced that the Company will release fiscal 2007 fourth quarter and full-year results

Company's Replacement Technology Represents Advance in Treatment of Varicose Veins

AngioDynamics Appoints John Soto to Lead Global Sales AngioDynamics Appoints John Soto to Lead Global Sales QUEENSBURY, N.Y.--(BUSINESS WIRE)--June 7, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the

NeverTouch(TM)VenaCure(R) Shipments Commenced June 1